Titelbild von Sysmex Europe HaemostasisSysmex Europe Haemostasis
Sysmex Europe Haemostasis

Sysmex Europe Haemostasis

Herstellung medizinischer Geräte

Garstedt, Schleswig-Holstein 2.501 Follower:innen

Expect the best. Haemostasis diagnostics powered by Sysmex

Info

Haemostasis is the body’s physiological method of maintaining blood circulation. The combination of complex actions between the blood vessel, smallest blood cells (platelets) and specific proteins in the plasma stop bleeding if a blood vessel is damaged.

Branche
Herstellung medizinischer Geräte
Größe
5.001–10.000 Beschäftigte
Hauptsitz
Garstedt, Schleswig-Holstein
Gegründet
1968

Updates

  • 🌍 #Sysmex at the 69th GTH Congress in Lausanne 🌍  Sysmex Europe is proud to emphasise Sysmex Suisse AG’s participation in the 69th Annual Meeting of the Society for Thrombosis and Haemostasis Research (GTH), held from 18 to 21 February 2025 in the picturesque city of Lausanne. Together with our Sysmex colleagues, we are committed to advancing the field of coagulation diagnostics. This congress serves as a vital platform for experts to explore the latest innovations and share pioneering approaches in haemostasis. Our Scientific Marketing Manager, Dr Andreas Rechner, was on site to engage with fellow professionals, foster collaboration, and discuss how Sysmex’s cutting-edge solutions can enhance diagnostic accuracy and patient outcomes. Attending such events broadens our knowledge base and strengthens our connections with healthcare professionals dedicated to improving coagulation diagnostics. Together, we can shape the future of haemostasis solutions, ensuring that healthcare providers have access to the most reliable tools for patient care. We look forward to insightful discussions and transformative ideas that emerge from this esteemed gathering. 💡👩⚕️👨⚕️ #GTH2025 #CoagulationDiagnostics #Haemostasis

    • Kein Alt-Text für dieses Bild vorhanden
  • 📢 Final call for tomorrow: DOACs and their impact on coagulation assays Don’t forget: 𝗧𝗼𝗺𝗼𝗿𝗿𝗼𝘄 𝗮𝘁 𝟭𝟭:𝟬𝟬 𝗔𝗠 𝗖𝗘𝗧 𝗼𝘂𝗿 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 ‘𝗧𝗵𝗲 𝗲𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗗𝗢𝗔𝗖𝘀 𝗼𝗻 𝗰𝗼𝗮𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝘀𝘀𝗮𝘆𝘀’ 𝘄𝗶𝗹𝗹 𝘀𝘁𝗮𝗿𝘁. Don’t miss this opportunity to learn about the influence of DOACs on #coagulation assays, plus current potential solutions and complementary workarounds. Direct oral anticoagulants (DOACs) are state-of-the-art anticoagulant agents that have a wide range of clinical applications. However, their mode of action (direct inhibition of factor Xa or thrombin (factor IIa)) can influence some assays used in the #coagulation lab. 🆓 Register here: https://lnkd.in/erRsGMZD Hoping to welcome you tomorrow! #Sysmex #CaresphereAcademy

    • Kein Alt-Text für dieses Bild vorhanden
  • 📅 𝗠𝗮𝗿𝗸 𝘆𝗼𝘂𝗿 𝗰𝗮𝗹𝗲𝗻𝗱𝗮𝗿𝘀! 𝗧𝗵𝗲 𝗲𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗗𝗢𝗔𝗖𝘀 𝗼𝗻 𝗰𝗼𝗮𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝘀𝘀𝗮𝘆𝘀 How do you validate your #coagulation lab assay results? Join our upcoming live webinar in our series of ‘Haemostasis and beyond’ to take in some cutting-edge knowledge on the impact of DOACs.💊 This webinar summarises 𝘁𝗵𝗲 𝗶𝗻𝗳𝗹𝘂𝗲𝗻𝗰𝗲 𝗼𝗳 𝗗𝗢𝗔𝗖𝘀 𝗼𝗻 𝗰𝗼𝗮𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝘀𝘀𝗮𝘆𝘀 𝗮𝗻𝗱 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝘀 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝗰𝗼𝗺𝗽𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝗿𝘆 𝘄𝗼𝗿𝗸𝗮𝗿𝗼𝘂𝗻𝗱𝘀. 𝗗𝗮𝘁𝗲: 𝟮𝟳.𝟬𝟮.𝟮𝟬𝟮𝟱 𝗧𝗶𝗺𝗲: 𝟭𝟭:𝟬𝟬 – 𝟭𝟭:𝟰𝟱 𝗖𝗘𝗧 Register here: https://lnkd.in/eMNtQfqd 💡 Why is it beneficial to attend the live session? Apart from the live atmosphere, you can address any questions or remarks you may have directly to the experts, and receive an immediate reply. #Sysmex #CaresphereAcademy

    • Kein Alt-Text für dieses Bild vorhanden
  • 📑 Halfway there! We’re happy to share that we’ve successfully crossed the halfway line of our ‘Haemostasis and beyond’ webinar series! This journey so far has been filled with fruitful discussions, knowledge sharing, and engagement on all sides. A huge ‘thank you’ 👏 to everyone who has joined us, contributed, and made this series a success. We’re excited about the upcoming meetings and hope your interest continues to grow as we go through even more critical topics in haemostasis. Don’t worry if you haven’t been able to join us yet. There’s still time to come aboard! 🛳 Stay tuned for upcoming sessions: https://lnkd.in/eWcZbBdG #Haemostasis #Sysmex

  • Unternehmensseite für Sysmex Europe Haemostasis anzeigen

    2.501 Follower:innen

    🔔 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 𝗿𝗲𝗰𝗼𝗿𝗱𝗶𝗻𝗴 𝗮𝗹𝗲𝗿𝘁: 𝗧𝗵𝗿𝗼𝗺𝗯𝗼𝗽𝗵𝗶𝗹𝗶𝗮 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 𝗜𝗜: 𝗔𝗣𝗖 𝗿𝗲𝘀𝗶𝘀𝘁𝗮𝗻𝗰𝗲, 𝗮𝗻𝘁𝗶𝗽𝗵𝗼𝘀𝗽𝗵𝗼𝗹𝗶𝗽𝗶𝗱 𝘀𝘆𝗻𝗱𝗿𝗼𝗺𝗲 & 𝗼𝘁𝗵𝗲𝗿 𝗰𝗼𝗻𝗱𝗶𝘁𝗶𝗼𝗻𝘀 In this 4th instalment of our webinar series ‘Haemostasis and beyond’, we focused on - decoding the mechanisms of action behind activated protein C resistance (APCR) and anti-phospholipid syndrome (APS). - mastering the proper diagnostic techniques for these common thrombophilic conditions. - gaining clarity on when, how, and which testing is essential for patients suspected of APCR or APS. Watch the recording and expand your knowledge on thrombophilia! 💡 Ideal for: Lab professionals, coagulation specialists, haematologists, cardiologists, neurologists, and oncologists. 𝗘𝗻𝗿𝗼𝗹 𝗵𝗲𝗿𝗲: https://lnkd.in/eMNtQfqd #Sysmex #Haemostasis #CaresphereAcademy

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite für Sysmex Europe Haemostasis anzeigen

    2.501 Follower:innen

    🥁 Webinar recording alert: Thrombophilia testing I: Antithrombin, Protein S & Protein C Our deep dive 🤿 into ‘Haemostasis and beyond’ continued with another fascinating webinar from our expert. In case you missed it… …watch the recording to - understand the mechanisms of action behind key thrombophilia drivers. - learn the classification, diagnosis, and management of antithrombin, protein C & S deficiencies, plasminogen deficiency, and elevated FVIII, FIX, & VWF levels. - gain clarity on when, how, and which thrombophilia testing is essential for your patients. 💡 Ideal for: Lab professionals, coagulation specialists, haematologists, cardiologists, neurologists, and oncologists. 𝗘𝗻𝗿𝗼𝗹 𝗵𝗲𝗿𝗲: https://lnkd.in/eMNtQfqd #Sysmex #Haemostasis #CaresphereAcademy

    • Kein Alt-Text für dieses Bild vorhanden
  • 𝗛𝗮𝗲𝗺𝗼𝘀𝘁𝗮𝘀𝗶𝘀 𝗶𝗻 𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀 Vascular diseases, such as atherosclerosis, are one of the most common causes of death or severe disabilities. Cardiovascular disease in the heart may result in myocardial infarction or acute heart failure, while cerebrovascular disease in the brain may trigger an ischaemic stroke. Both events are characterised by the formation of a thrombus in the atherosclerotic arteries. This webinar explains the connection between atherosclerosis, vascular diseases and haemostasis, and introduces relevant treatment and management concepts. 𝗝𝗼𝗶𝗻 𝘂𝘀 𝗻𝗲𝘅𝘁 𝘄𝗲𝗲𝗸 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆, 𝗼𝗻 𝟭𝟯 𝗙𝗲𝗯, 𝟭𝟭:𝟬𝟬 𝗔𝗠 𝗖𝗘𝗧 (𝗘𝗻𝗴𝗹𝗶𝘀𝗵)! Link: https://lnkd.in/e29YRK-Q

  • 𝗛𝗮𝗲𝗺𝗼𝘀𝘁𝗮𝘀𝗶𝘀 𝗶𝗻 𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀 Join us for a comprehensive webinar exploring the intricate mechanisms of haemostasis and its role in vascular diseases. Discover cutting-edge research, clinical insights, and therapeutic strategies to manage bleeding disorders and thrombosis. - 𝗗𝗮𝘁𝗲: 13.02.2025 - 𝗧𝗶𝗺𝗲: 11:00 - 11:45 CEST Don't miss this opportunity to expand your knowledge and network with the expert in the field. #Sysmex #Haemostasis

    • Kein Alt-Text für dieses Bild vorhanden
  • If you live in the Netherlands or Belgium, don't miss out on the Sysmex haemostasis days on the 4th and 13th of February respectively! Our Benelux colleagues have organised a full day of interesting lectures and exciting panel discussions on a variety of topics related to haemostasis. Follow the links below and register for the event, hope to see you there! 

    Unternehmensseite für Sysmex Netherlands & Belgium anzeigen

    5.521 Follower:innen

    On the 4th and the 13th of february we are organising the Sysmex Haemostasis Days, one in the Netherlands and one in Belgium! 🙌 This first haemostasis event is a great opportunity for networking and future collaborations in the field of haemostasis. During these days, you will have the opportunity to listen to inspiring lectures and participate in panel discussions. Visit our Caresphere Academy for more information and to register directly. 👉 Click here for the Belgian Sysmex Haemostasis Day on the 4th of February 2025: https://bit.ly/3ZKMXrz 👉 Klik hier voor de Nederlandse Hemostase Dag op 13 februari 2025: https://bit.ly/41hw1tz We are looking forward to meeting you at one of these days!  #Haemostasis #CaresphereAcademy #SysmexBNL

    • Kein Alt-Text für dieses Bild vorhanden
  • 𝗔𝗻𝘁𝗶𝗰𝗼𝗮𝗴𝘂𝗹𝗮𝗻𝘁 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 Join us to explore the latest testing strategies for VKAs, heparins, and DOACs. We'll discuss best practices to ensure patient safety and achieve optimal treatment outcomes. Real-world case studies will also be used to illustrate key concepts. What you will learn: ✅ Why and when anticoagulation is needed and what are the drugs of choice for the various thrombotic disorders ✅ Mechanism of action and clinical indications of anticoagulants ✅ Methods routinely used to measure the effect of anti-platelet and anticoagulant drugs Join us on Jan 16th, 11:00 AM CET (English)! Register here: https://lnkd.in/esQxieXh #Sysmex #CaresphereAcademy

Verbundene Seiten

Ähnliche Seiten